US Patent Issued to Helmholtz Zentrum Munchen-Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH) on March 24 for "Antibodies against IGFR-like receptor and uses thereof" (German Inventor)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,928, issued on March 24, was assigned to Helmholtz Zentrum Munchen-Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH) (Neuherberg, Germany).

"Antibodies against IGFR-like receptor and uses thereof" was invented by Heiko Lickert (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a novel IGFR-like receptor and antagonists and agonists for targeting said receptor. Said antagonists and agonists are envisaged for use as a medicament, and in particular for treatment of diabetes."

The patent was filed on Feb. 24, 2022, under Application No. 17/679,545.

*For further information, including images, charts and ta...